Pharmafile Logo
Pharmafocus logo
Advanced Search

US FDA committee recommends approval of Sanofi’s combination therapy for type 2 diabetes

May 26, 2016
Research and Development, Sales and Marketing

French drug firm Sanofi (Euronext: SAN) said the US Food and Drug Administration (FDA) advisory committee has recommended the approval …

News
clinical_trial_4

FDA approves CSL haemophilia A drug

May 26, 2016
Sales and Marketing CSL, afstyla, haemophilia a, treatment

CSL (ASX: CSL) has announced that the US Food and Drug Administration (FDA) has approved Afstyla (antihaemophilic factor [recombinant), single …

News

NICE recommends Jevtana for advanced prostate cancer

May 25, 2016
Sales and Marketing Jevtana, NICE, approval, prostate cancer, recommendation

The National Institute for Health and Care Excellence (NICE) has recommended Sanofi Genzyme’s Jevtana (cabazitaxel), in combination with prednisone or …

News
sanofi_hq__boetie_hall

Sanofi makes move to remove Medivation board; Medivation hits back

May 25, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medivation, Sanofi, removal of board, takeover

Sanofi (NYSE: SNY) has taken their proposed takeover of Medivation (NASDAQ: MDVN) up several notches, with the French company filing …

News
gilead-sciences

Gilead names Kevin Young new chief operating officer

May 25, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead

Gilead Sciences (NASDAQ: GILD) has announced two new senior appointments, including Kevin Young as its new chief operating officer. Martin …

Appointment
lilly_entrance_web

Eli Lilly showcases emerging pipeline to investors

May 25, 2016
Research and Development Eli Lilly, investors, lilly, pipeline, research and development

Eli Lilly and Co (NYSE: LLY) has showcased its emerging pipeline to potential investors, highlighting its potential to launch 20 …

News

Monsanto rejects Bayer’s $62 billion offer

May 25, 2016
Business Services, Research and Development, Sales and Marketing Bayer, Financial, M&A, MA, deal, monsanto

World’s largest seed maker Monsanto (NYSE: MON) has rejected the $62 billion takeover offer from Germany’s Bayer AG (ETR: BAYN) …

News
novo_flag

FDA committee unanimously recommends Novo Nordisk diabetes combo, IDegLira

May 25, 2016
Research and Development, Sales and Marketing FDA, Novo Nordisk, Panel, Tresiba, Victoza, committee, ideglira, recommendation, staff

Novo Nordisk has announced that a US Food and Drug Administration (FDA) advisory committee has unanimously recommended IDegLira, a type-2 …

News

Nice recommends three drugs to treat diabetes

May 25, 2016
Research and Development, Sales and Marketing AstraZeneca, BMS, Boehringer Ingelheim, Eli Lilly, Janssen, NICE, diabetes

The National Institute for Health and Care Excellence (Nice) has backed three drugs for the treatment of type 2 diabetes. …

News

Rare disease treatment advocates criticise NHS delays in commissioning

May 24, 2016
Medical Communications, Sales and Marketing NHS, commissioning

Medical professionals are calling on NHS England to speed up access to treatment for patients with a rare genetic disease …

News

GSK says asthma drug Breo shows superior results over standard care in major study

May 24, 2016
Research and Development, Sales and Marketing COPD, GSK, asthma, breo, drug trial

UK drugmaker GlaxoSmithKline (LSE: GSK) on Tuesday said inhaled medicine Breo proved significantly better than standard care in a major …

News

Focus: Regulators Enter the Drug Pricing Debate

May 24, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, pharma industry, regulation

By Anjali Shukla The Chinese authorities have come down strongly on the issue of drug costs, slashing the prices of …

Feature
test_results

MOD to ban use of Roche anti-malaria drug, Lariam, for armed forces

May 24, 2016
Manufacturing and Production, Sales and Marketing anti-malaria drug, armed forces, lariam, mod

A parliamentary committee has published a new report urging the armed forces not to use anti-malaria drug, Lariam, due to …

News

Pfizer says EMA lifts warning on its smoking cessation drug Champix

May 24, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Champix, EMA, Pfizer, anti-smoking, drug trial

US pharma giant Pfizer (NYSE: PFE) said the European Medicines Agency has lifted a warning on its anti-smoking drug Champix …

News
needles

CSL’s flu vaccine scores FDA approval

May 24, 2016
Manufacturing and Production, Research and Development, Sales and Marketing CSL, FDA, Vaccine, flu, four strain, four-strain, influenza, influenza a, influenza b, seqirus

Seqirus, a division of CSL, has announced that the US Food and Drug Administration (FDA) has approved Flucelvax Quadrivalent (influenza …

News
ema_building_face_web

Sandoz biosimilar accepted for regulatory submission by EMA

May 24, 2016
Manufacturing and Production, Research and Development, Sales and Marketing EMA, Sandoz, biosimilar

Sandoz, a division of Novartis, has announced that the European Medicines Agency (EMA) has accepted its marketing authorisation application for …

News

US FDA advisors question usefulness of Sanofi’s combination diabetes therapy

May 24, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, US FDA, diabetes, drug trial, regulation

US Food and Drug Administration staff questioned the benefits of French drugmaker Sanofi’s (Euronext: SAN) diabetes drug candidate as well …

News
lab

French authorities pins blame on Bial and Biotrial for fatal drug trial

May 24, 2016
Manufacturing and Production, Research and Development Bial, Biotrial, France, blame, clinical trial, death, disaster, minister for health, report

Authorities in France have criticised the pharmaceutical company and the clinical research organisation at the centre of the Rennes clinical …

News
janssen_latest_logo_on_sign

Janssen’s Darzalex gets conditional European Commission approval to treat multiple myeloma

May 24, 2016
Manufacturing and Production, Research and Development, Sales and Marketing

Janssen said the European Commission (EC) conditionally approved its biologic Darzalex (daratumumab) to treat blood cancer.  The company said Daratumumab …

News
pauljenkinson

Kite Pharma names Paul Jenkinson CFO

May 23, 2016
Research and Development, Sales and Marketing appointment, cfo, kite pharma

Kite Pharma (Nasdaq: KITE) has appointed Paul Jenkinson its chief financial officer. Jenkinson succeeds Cynthia Butitta, who will continue in her role as …

Appointment
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026